KYTHERA Biopharmaceuticals Announces IPO Pricing Thursday, October 11, 3:16 PM ET
KYTHERA Biopharmaceuticals announced the pricing of its initial public offering of 4,400,000 shares of its common stock at a price to the public of $16.00 per share. The shares of KYTHERA's common stock will trade on the NASDAQ under the symbol "KYTH." KYTHERA has granted the underwriters a 30-day option to purchase up to an additional 660,000 shares of common stock to cover over-allotments
The offering is expected to close on October 16, 2012
J.P. Morgan Securities Goldman Sachs are acting as joint book-running managers for the offering. Leerink Swann is acting as lead co-manager and Lazard Capital Markets is acting as co-manager.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.